Hester Biosciences Ltd. logo

Hester Biosciences Ltd. (HESTERBIO)

Market Closed
10 Aug, 10:00
XNSE XNSE
2,493. 80
+75.9
+3.1391%
20.26B Market Cap
71.95 P/E Ratio
24% Div Yield
11,921 Volume
0 Eps
2,417.9
Previous Close
Add Transaction
Day Range
2,399.1 2,519.8
Year Range
1,239.3 2,683.6
Want to track HESTERBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HESTERBIO closed today higher at ₹2,493.8, an increase of 3.1391% from yesterday's close, completing a monthly increase of 15.1924% or ₹328.9. Over the past 12 months, HESTERBIO stock gained 55.6193%.
HESTERBIO pays dividends to its shareholders, with the most recent payment made on Jul 28, 2026. The next estimated payment will be in In 11 months on Jul 28, 2027 for a total of ₹11.
The last earnings report, released on May 30, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Hester Biosciences Ltd. has completed 1 stock splits, with the recent split occurring on Sep 27, 2012.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

HESTERBIO Chart

People also search for

Wockhardt Ltd.
1,931.2
-4.4433%
Piramal Pharma Ltd.
213.61
+1.9375%
CIE Automotive India Ltd.
409.5
-0.2436%
Ola Electric Mobility Ltd.
39.3
-4.3097%
Natco Pharma Ltd.
910.5
-0.6709%

Hester Biosciences Ltd. (HESTERBIO) FAQ

What is the stock price today?

The current price is ₹2,493.80.

On which exchange is it traded?

Hester Biosciences Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is HESTERBIO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 24%.

What is its market cap?

As of today, the market cap is 20.26B.

Has Hester Biosciences Ltd. ever had a stock split?

Hester Biosciences Ltd. had 1 splits and the recent split was on Sep 27, 2012.

Hester Biosciences Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Rajiv Dinesh Gandhi B.Com CEO
XNSE Exchange
Y3180C102 CUSIP
India Country
642 Employees
14 Jul 2026 Last Dividend
27 Sep 2012 Last Split
- IPO Date

Overview

Hester Biosciences Limited is a prominent entity in the field of animal healthcare, dealing extensively in the production and trading of veterinary vaccines and related health products both in India and on an international scale. With a diversified operational structure, the company focuses on various segments, including Poultry Healthcare, Animal Healthcare, Petcare, and Others. Since its inception in 1987, Hester Biosciences has established itself as a key player in the industry, with its headquarters located in Ahmedabad, India. Its comprehensive portfolio caters to a broad spectrum of animal health needs, demonstrating a commitment to improving disease resistance and overall health in animals.

Products and Services

  • Poultry Vaccines: These vaccines are designed to protect poultry against a wide array of diseases such as newcastle disease, infectious bronchitis, fowl pox, and marek's disease, among others. By providing immunity against common and severe avian illnesses, Hester Biosciences aids in sustaining the poultry industry’s health standards and productivity.
  • Livestock Vaccines: Catering to the broader livestock sector, the company offers vaccines for goat pox, peste des petits ruminants (PPR), and lumpy skin diseases. These vaccines play a crucial role in preventing outbreaks of significant diseases in goats, sheep, and cattle, ensuring livestock wellness and economic stability for farmers.
  • Animal Health Products: Beyond vaccines, Hester Biosciences provides a range of health products including biosecurity solutions, therapeutic remedies, herbal and homeopathic supplements, and feed supplements. These products aim to enhance the overall wellbeing and productivity of animals through disease prevention, nutritional support, and improved farm management practices.
  • Pet Care Products: The company’s pet care range addresses the health and grooming needs of pets, offering products such as non-steroidal anti-inflammatory drugs (NSAIDs), joint care formulations, parasiticide solutions, and grooming aids. Tailored to improve the quality of life for pets, these products underscore Hester Biosciences’ dedication to companion animal health.
  • Diagnostic Kits: To support disease detection and management, Hester Biosciences supplies enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) kits. These diagnostic tools are essential for accurate disease surveillance and control in both poultry and livestock, enabling timely and informed decision-making in animal husbandry.

Contact Information

Address: Pushpak
Phone: 91 79 2644 5107